| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |